Due to changes in the collection and availability of data on COVID-19, this dataset is no longer updated. Latest information about COVID-19 is available via the UKHSA data dashboard. The UK government publish daily data, updated weekly, on COVID-19 cases, vaccinations, hospital admissions and deaths. This note provides a summary of the key data for London from this release. Data are published through the UK Coronavirus Dashboard, last updated on 23 March 2023. This update contains: Data on the number of cases identified daily through Pillar 1 and Pillar 2 testing at the national, regional and local authority level Data on the number of people who have been vaccinated against COVID-19 Data on the number of COVID-19 patients in Hospital Data on the number of people who have died within 28 days of a COVID-19 diagnosis Data for London and London boroughs and data disaggregated by age group Data on weekly deaths related to COVID-19, published by the Office for National Statistics and NHS, is also available. Key Points On 23 March 2023 the daily number of people tested positive for COVID-19 in London was reported as 2,775 On 23 March 2023 it was newly reported that 94 people in London died within 28 days of a positive COVID-19 test The total number of COVID-19 cases identified in London to date is 3,146,752 comprising 15.2 percent of the England total of 20,714,868 cases In the most recent week of complete data (12 March 2023 - 18 March 2023) 2,951 new cases were identified in London, a rate of 33 cases per 100,000 population. This compares with 2,883 cases and a rate of 32 for the previous week In England as a whole, 29,426 new cases were identified in the most recent week of data, a rate of 52 cases per 100,000 population. This compares with 26,368 cases and a rate of 47 for the previous week Up to and including 22 March 2023 6,452,895 people in London had received the first dose of a COVID-19 vaccine and 6,068,578 had received two doses Up to and including 22 March 2023 4,435,586 people in London had received either a third vaccine dose or a booster dose On 22 March 2023 there were 1,370 COVID-19 patients in London hospitals. This compares with 1,426 patients on 15 March 2023. On 22 March 2023 there were 70 COVID-19 patients in mechanical ventilation beds in London hospitals. This compares with 72 patients on 15 March 2023. Update: From 1st July updates are weekly From Friday 1 July 2022, this page will be updated weekly rather than daily. This change results from a change to the UK government COVID-19 Dashboard which will move to weekly reporting. Weekly updates will be published every Thursday. Daily data up to the most recent available will continue to be added in each weekly update. Data summary 리소스 CSV phe_vaccines_age_london_boroughs.csv CSV 다운로드 phe_vaccines_age_london_boroughs.csv CSV phe_healthcare_admissions_age.csv CSV 다운로드

In early-February 2020, the first cases of COVID-19 in the United Kingdom (UK) were confirmed. As of December 2023, the South East had the highest number of confirmed first episode cases of the virus in the UK with 3,180,101 registered cases, while London had 2,947,727 confirmed first-time cases. Overall, there has been 24,243,393 confirmed cases of COVID-19 in the UK as of January 13, 2023.

COVID deaths in the UK COVID-19 was responsible for 202,157 deaths in the UK as of January 13, 2023, and the UK had the highest death toll from coronavirus in western Europe. The incidence of deaths in the UK was 297.8 per 100,000 population as January 13, 2023.

Current infection rate in Europe The infection rate in the UK was 43.3 cases per 100,000 population in the last seven days as of March 13, 2023. Austria had the highest rate at 224 cases per 100,000 in the last week.

For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page.

On March 4, 2020, the first death as a result of coronavirus (COVID-19) was recorded in the United Kingdom (UK). The number of deaths in the UK has increased significantly since then. As of January 13, 2023, the number of confirmed deaths due to coronavirus in the UK amounted to 202,157. On January 21, 2021, 1,370 deaths were recorded, which was the highest total in single day in the UK since the outbreak began.

Number of deaths among highest in Europe
The UK has had the highest number of deaths from coronavirus in western Europe. In terms of rate of coronavirus deaths, the UK has recorded 297.8 deaths per 100,000 population.

Cases in the UK The number of confirmed cases of coronavirus in the UK was 24,243,393 as of January 13, 2023. The South East has the highest number of first-episode confirmed cases of the virus in the UK with 3,123,050 cases, while London and the North West have 2,912,859 and 2,580,090 confirmed cases respectively. As of January 16, the UK has had 50 new cases per 100,000 in the last seven days.

For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page.

This paper summarises the latest evidence and analysis on the impacts of COVID-19 on London’s economy so far and on the economic outlook so that key actors and stakeholders engaged in responding to the pandemic can have a readily available evidence base to inform policy responses.

Age-standardised mortality rates for deaths involving coronavirus (COVID-19), non-COVID-19 deaths and all deaths by vaccination status, broken down by age group.

There were 11,607 deaths registered in England and Wales for the week ending February 21, 2025, compared with 12,365 in the previous week. During this time period, the two weeks with the highest number of weekly deaths were in April 2020, with the week ending April 17, 2020, having 22,351 deaths, and the following week 21,997 deaths, a direct result of the COVID-19 pandemic in the UK. Death and life expectancy As of 2022, the life expectancy for women in the UK was just over 82.5 years, and almost 78.6 years for men. Compared with 1765, when average life expectancy was under 39 years, this is a huge improvement in historical terms. Even in the more recent past, life expectancy was less than 47 years at the start of the 20th Century, and was under 70 as recently as the 1950s. Despite these significant developments in the long-term, improvements in life expectancy stalled between 2009/11 and 2015/17, and have even gone in decline since 2020. Between 2020 and 2022, for example, life expectancy at birth fell by 23 weeks for females, and 37 weeks for males.2. COVID-19 in the UK The first cases of COVID-19 in the United Kingdom were recorded on January 31, 2020, but it was not until a month later that cases began to rise exponentially. By March 5 of this year there were more than 100 cases, rising to 1,000 days later and passing 10,000 cumulative cases by March 26. At the height of the pandemic in late April and early May, there were around six thousand new cases being recorded daily. As of January 2023, there were more than 24.2 million confirmed cumulative cases of COVID-19 recorded in the United Kingdom, resulting in 202,156 deaths.

As of January 3, 2021. it was found that around 65 percent of survey respondents in the United Kingdom had been wearing a face mask outside to protect themselves and others from the coronavirus (COVID-19). The share of people wearing a mask in the UK has increased significantly since March, when only eight percent of respondents were always wearing a face mask outside, while according to the latest survey wave eleven percent reported never wearing a mask. Across the four countries of the UK, there hads been differing timings of regulations to make the wearing of face masks mandatory in public places. Compared to the UK, some other European countries introduced the wearing of face masks earlier into the pandemic.

The latest number of cases in the UK can be found here. For further information about the coronavirus pandemic, please visit our dedicated Facts and Figures page.

Provisional counts of deaths in care homes caused by coronavirus (COVID-19) by local authority. Published by the Office for National Statistics and Care Quality Commission.

Further information about the study may be found on the COVID Social Mobility and Opportunities Study (COSMO) webpage.

Further information about the study may be found on the COSMO website.

Abstract copyright UK Data Service and data collection copyright owner.

The COVID Social Mobility and Opportunities Study (COSMO) is a longitudinal cohort study, a collaboration between the UCL Centre for Education Policy and Equalising Opportunities (CEPEO), the UCL Centre for Longitudinal Studies (CLS), and the Sutton Trust. The overarching aim of COSMO is to provide a representative data resource to support research into how the COVID-19 pandemic affected the life chances of pupils with different characteristics, in terms of short-term effects on educational attainment, and long-term educational and career outcomes.

The topics covered by COSMO include, but are not limited to, young people's education experiences during the pandemic, cancelled assessments and education and career aspirations. They have also been asked for consent for linking their survey data to their administrative data held by organisations such as the UK Department for Education (DfE). Linked data is planned to be made available to researchers through the ONS Secure Research Service.

Young people who were in Year 11 in the 2020-2021 academic year were drawn as a clustered and stratified random sample from the National Pupil Database held by the DfE, as well as from a separate sample of independent schools from DfE's Get Information about Schools database. The parents/guardians of the sampled young people were also invited to take part in COSMO. Data from parents/guardians complement the data collected from young people.

Further information about the study may be found on the COVID Social Mobility and Opportunities Study (COSMO) webpage.

COSMO Wave 2, 2022-2023
All young people who took part in Wave 1 (see SN 9000) were invited to the second Wave of the study, along with their parents (whether or not they took part in Wave 1).

Data collection in Wave 2 was carried out between October 2022 and April 2023 where young people and parents/guardians were first invited to a web survey. In addition to online reminders, some non-respondents were followed up via face-to-face visits or telephone calls over the winter and throughout spring. Online ‘mop-up’ fieldwork was also carried out to invite all non-respondents into the survey one last time before the end of fieldwork.

Latest edition information:
For the second edition (April 2024), a standalone dataset from the Keeping in Touch (KIT) exercise carried out after the completion of Wave 2, late 2023 have been deposited. This entailed a very short questionnaire for updating contact details and brief updates on young people's lives. A longitudinal parents dataset has also been deposited, to help data users find core background information from parents who took part in either Wave 1 or Wave 2 in one place. Finally, the young people's dataset has been updated (version 1.1) with additional codes added from some open-ended questions. The COSMO Wave 1 Data User Guide Version 1.1 explains these updates in detail. A technical report and accompanying appendices has also been deposited.

Further information about the study may be found on the COSMO website.

For young people, Wave 2 included:

• a household grid
• changes to current status since Wave 1
• qualifications studied towards
• early labour market experience
• residual disruption due to the pandemic
• university applications
• attitudes to education and future careers
• spare time/leisure activities
• homelessness
• health and wellbeing
• friends, peers and family support
• health-related behaviours.

For parents, Wave 2 included:

• demographics
• attitudes to education/education and career aspirations
• parenting, home learning, tuition and catch-up
• working status across the pandemic (since the last interview for parents also interviewed in Wave 1)
• parental tenure, HRP and occupation details
• parental education
• parental income
• grandparents
• COVID-19 history and vaccination
• parent health and wellbeing
• disadvantage.

COVID-19 causes significant mortality in elderly and vulnerable people and spreads easily in care homes where one in seven individuals aged > 85 years live. However, there is no surveillance for infection in care homes, nor are there systems (or research studies) monitoring the impact of the pandemic on individuals or systems. Usual practices are disrupted during the pandemic, and care home staff are taking on new and unfamiliar roles, such as advanced care planning. Understanding the nature of these changes is critical to mitigate the impact of COVID-19 on residents, relatives and staff. 20 care homes staff members were interviewed using semi-structured interviews.

The COVID-19 pandemic poses a substantial risk to elderly and vulnerable care home residents and COVID-19 can spread rapidly in care homes. We have national, daily data on people with COVID-19 and deaths, but there is no similar data for care homes. This makes it difficult to know the scale of the problem, and plan how to keep care home residents safe. We also want to understand the impact of COVID-19 on care home staff and residents. Researchers from University College London (UCL) will measure the number of cases of COVID-19 in care homes, using data from Four Seasons Healthcare, a large care home chain. FSHC remove residents' names and addresses before sending the dataset to UCL, protecting resident's confidentiality. Since we cannot visit care homes during the pandemic, we will hold virtual (online) discussion meetings with care home stakeholders (staff, residents, relatives, General Practice teams) every 6-8 weeks, to learn rapid lessons about managing COVID-19 in care homes and identify pragmatic solutions. Our findings will be shared with FHSC, GPs and Public Health England, patients and the public, and support the national response to COVID-19. Patients and the public will be involved in all stages of the research.

Abstract copyright UK Data Service and data collection copyright owner.

The Centre for Longitudinal Studies (CLS) and the MRC Unit for Lifelong Health and Ageing (LHA) have carried out two online surveys of the participants of five national longitudinal cohort studies which have collected insights into the lives of study participants including their physical and mental health and wellbeing, family and relationships, education, work, and finances during the coronavirus pandemic. The Wave 1 Survey was carried out at the height of lockdown restrictions in May 2020 and focussed mainly on how participants’ lives had changed from just before the outbreak of the pandemic in March 2020 until then. The Wave 2 survey was conducted in September/October 2020 and focussed on the period between the easing of restrictions in June through the summer into the autumn. A third wave of the survey was conducted in early 2021.

In addition, CLS study members who had participated in any of the three COVID-19 Surveys were invited to provide a finger-prick blood sample to be analysed for COVID-19 antibodies. Those who agreed were sent a blood sample collection kit and were asked to post back the sample to a laboratory for analysis. The antibody test results and initial short survey responses are included in a single dataset, the COVID-19 Antibody Testing in the National Child Development Study, 1970 British Cohort Study, Next Steps and Millennium Cohort Study, 2021 (SN 8823).

The CLS studies are:

• Millennium Cohort Study (born 2000-02) both cohort members and parents (MCS)
• Next Steps (born 1989-90) (NS)
• 1970 British Cohort Study (BCS70)
• 1958 National Child Development Study (NCDS).

The LHA study is:

• MRC National Survey of Health and Development, 1946 British birth cohort (NSHD)

The content of the MCS, NS, BCS70 and NCDS COVID-19 studies, including questions, topics and variables can be explored via the CLOSER Discovery website.

The COVID-19 Survey in Five National Longitudinal Cohort Studies: Millennium Cohort Study, Next Steps, 1970 British Cohort Study and 1958 National Child Development Study, 2020-2021 contains the data from waves 1, 2 and 3 for the 4 cohort studies. The data from all four CLS cohorts are included in the same dataset, one for each wave.

The COVID-19 Survey data for the 1946 birth cohort study (NSHD) run by the LHA is held under SN 8732 and available under Special Licence access conditions.

Latest edition information
For the fourth edition (June 2022), the following minor corrections have been made to the wave 3 data:

• corrections to a small number of cases where CW3_GROW and CW3_GROWB were incorrectly calculated
• recoded values and reformatted the code list for CW3_COVIDVAC as the original value of 3 was removed from the final version of the survey
  

The study covers physical and mental health topics, wellbeing, family and relationships, education, work, and finances.

Abstract copyright UK Data Service and data collection copyright owner.

• construct waves of accessible and well-documented panel data;
• provide these data in a convenient and timely fashion to the scientific and policy research community;
• describe health trajectories, disability and healthy life expectancy in a representative sample of the English population aged 50 and over;
• examine the relationship between economic position and health;
• nvestigate the determinants of economic position in older age;
• describe the timing of retirement and post-retirement labour market activity; and
• understand the relationships between social support, household structure and the transfer of assets.

Further information may be found on the the ELSA project website or the Natcen Social Research: ELSA web pages.

Health conditions research with ELSA - June 2021

The ELSA Data team have found some issues with historical data measuring health conditions. If you are intending to do any analysis looking at the following health conditions, then please contact the ELSA Data team at NatCen on elsadata@natcen.ac.uk for advice on how you should approach your analysis. The affected conditions are: eye conditions (glaucoma; diabetic eye disease; macular degeneration; cataract), CVD conditions (high blood pressure; angina; heart attack; Congestive Heart Failure; heart murmur; abnormal heart rhythm; diabetes; stroke; high cholesterol; other heart trouble) and chronic health conditions (chronic lung disease; asthma; arthritis; osteoporosis; cancer; Parkinson's Disease; emotional, nervous or psychiatric problems; Alzheimer's Disease; dementia; malignant blood disorder; multiple sclerosis or motor neurone disease).

Special Licence Data:

Special Licence Access versions of ELSA have more restrictive access conditions than versions available under the standard End User Licence (see 'Access' section below). Users are advised to obtain the latest edition of SN 5050 (the End User Licence version) before making an application for Special Licence data, to see whether that is suitable for their needs. A separate application must be made for each Special Licence study.

Special Licence Access versions of ELSA include:

• Primary data from Wave 8 onwards (SN 8346) includes all the variables in the EUL primary dataset (SN 5050) as well as year and month of birth, consolidated ethnicity and country of birth, marital status, and more detailed medical history variables.
• Wave 8 Pension Age Data (SN 8375) includes all the variables in the EUL pension age data (SN 5050) as well as year and age reached state pension age variables.
• Wave 8 Sexual Self-Completion Data (SN 8376) includes sensitive variables from the sexual self-completion questionnaire.
• Wave 3 (2007) Harmonized Life History (SN 8831) includes retrospective information on previous histories, specifically, detailed data on previous partnership, children, residential, health, and work histories.
• Detailed geographical identifier files for Waves 1-10 which are grouped by identifier held under SN 8429 (Local Authority District Pre-2009 Boundaries), SN 8439 (Local Authority District Post-2009 Boundaries), SN 8430 (Local Authority Type Pre-2009 Boundaries), SN 8441 (Local Authority Type Post-2009 Boundaries), SN 8431 (Quintile Index of Multiple Deprivation Score), SN 8432 (Quintile Population Density for Postcode Sectors), SN 8433 (Census 2001 Rural-Urban Indicators), SN 8437 (Census 2011 Rural-Urban Indicators).

Where boundary changes have occurred, the geographic identifier has been split into two separate studies to reduce the risk of disclosure. Users are also only allowed one version of each identifier:

• either SN 8429 (Local Authority District Pre-2009 Boundaries) or SN 8439 (Local Authority District Post-2009 Boundaries)
• either SN 8430 (Local Authority Type Pre-2009 Boundaries) or SN 8441(Local Authority Type Post-2009 Boundaries)
• either SN 8433 (Census 2001 Rural-Urban Indicators) or SN 8437 (Census 2011 Rural-Urban Indicators)

ELSA Wave 6 and Wave 8 Self-Completion Questionnaires included an open-ended question where respondents could add any other comments they may wish to note down. These responses have been transcribed and anonymised. Researchers can request access to these transcribed responses for research purposes by contacting the...

Notes:

For the week ending March 7, 2025, weekly deaths in England and Wales were 124 below the number expected, compared with 460 fewer than expected in the previous week. In late 2022, and through early 2023, excess deaths were elevated for a number of weeks, with the excess deaths figure for the week ending January 13, 2023, the highest since February 2021. In the middle of April 2020, at the height of the Coronavirus (COVID-19) pandemic, there were almost 12,000 excess deaths a week recorded in England and Wales. It was not until two months later, in the week ending June 19, 2020, that the number of deaths began to be lower than the five-year average for the corresponding week. Most deaths since 1918 in 2020 In 2020, there were 689,629 deaths in the United Kingdom, making that year the deadliest since 1918, at the height of the Spanish influenza pandemic. As seen in the excess death figures, April 2020 was by far the worst month in terms of deaths during the pandemic. The weekly number of deaths for weeks 16 and 17 of that year were 22,351, and 21,997 respectively. Although the number of deaths fell to more usual levels for the rest of that year, a winter wave of the disease led to a high number of deaths in January 2021, with 18,676 deaths recorded in the fourth week of that year. For the whole of 2021, there were 667,479 deaths in the UK, 22,150 fewer than in 2020. Life expectancy in the UK goes into reverse In 2022, life expectancy at birth for women in the UK was 82.6 years, while for men it was 78.6 years. This was the lowest life expectancy in the country for ten years, and came after life expectancy improvements stalled throughout the 2010s, and then declined from 2020 onwards. There is also quite a significant regional difference in life expectancy in the UK. In the London borough of Kensington and Chelsea, for example, the life expectancy for men was 81.5 years, and 86.5 years for women. By contrast, in Blackpool, in North West England, male life expectancy was just 73.1 years, while for women life expectancy was lowest in Glasgow, at 78 years.

In 2023, digital outdoor advertising revenue in the United Kingdom (UK) continued on its upward trajectory, reaching 841 million british pounds. A year earlier, it bounced back to the level seen before the COVID-19 pandemic hit the world. In 2019, it stood at 694 million British pounds and in 2022 at 750 million. In between, it fell to 415 million. Outdoor advertising is going digital Digital out-of-home (DOOH) advertising refers to any form of digital visual advertising media found outside the home. Examples of DOHH media include digital screens and electronic billboards, which, compared to traditional out-of-home (OOH) channels, offer dynamic real-time messaging that can be controlled remotely. In 2019, OOH advertising expenditure in the UK amounted to 1.3 billion British pounds, with the digital share of the UK’s OOH advertising revenue reaching 53 percent. While spending on digital outdoor promotion dropped by almost 40 percent in 2020 as a result of the coronavirus (COVID-19) pandemic, latest market data shows a swift recovery and DOOH advertising spending growth of over 12 percent in 2023. DOOH trends in the UK By going digital, companies can offer a wide array of new exciting features, including brighter colors, movement, interaction, and more advertising variation in general. One of the UK’s most well-known examples of the DOOH phenomenon is London’s Piccadilly Circus. In early 2020, roadside ads generated the highest digital outdoor advertising revenue in the UK, followed by retail and transport. While all outdoor advertising environments experienced an unprecedented drop in revenue in 2020, the number of DOOH screens in Great Britain remained relatively steady.